Repka, M.X., Kraker, R.T., Holmes, J.M., Summers, A.I., Glaser, S.R., Barnhardt, C.N., et al. and Pediatric Eye Disease Investigator Group (2014) Atropine vs Patching for Treatment of Moderate Amblyopia: Follow-Up at 15 Years of Age of a Randomized Clinical Trial. JAMA Ophthalmology, 132, 799-805.
https://doi.org/10.1001/jamaophthalmol.2014.392

has been cited by the following article:

• TITLE: An Update of the Recent Developments on Amblyopia

  AUTHORS: Abdulmajeed Alharbi, Hosam Dahaim Al Harbi

  KEYWORDS: Amblyopia, Visual Circuit, Anisometropic Amblyopia, Strabismus, Visual Dep-rivation, Reverse Amblyopia, Occlusion, Binocular Therapy, Penalisation, Or-thoptics

  JOURNAL NAME: Open Journal of Ophthalmology, Vol.10 No.3, August 26, 2020

  ABSTRACT: Amblyopia is a neurodevelopmental disorder of the visual cortex arising from abnormal visual experience early in life. Amblyopia is a major cause of impaired vision in infants and young children (prevalence around 3.5%). There are different treatment options for amblyopia based on its severity and age of the patient. Traditional treatments include patching or occlusion of the dominant eye and pharmacological penalisation using Atropine (1%). Recent developments in amblyopia management have found success with the use of binocular exercises and certain modifications of glasses and contact lenses. The critical age up to which amblyopia is treatable or reversible is also being pushed up with more research. With newer advancements in amblyopia therapy, the success rate is also improving with multimodal approach.